Tobias Rautio

Publications

2024

Tobias Rautio, Robin Obrist, Lucas Krebs, Therése Klingstedt, Johan Dahlén, Xiongyu Wu, Henrik Green (2024) In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references Drug Testing and Analysis (Article in journal) Continue to DOI

Karin Lindbom, Caitlyn Norman, Steven Baginski, Lucas Krebs, Darta Stalberga, Tobias Rautio, Xiongyu Wu, Robert Kronstrand, Henrik Green (2024) Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples Drug Testing and Analysis (Article in journal) Continue to DOI

2023

Steven R. Baginski, Tobias Rautio, Lorna A. Nisbet, Karin Lindbom, Xiongyu Wu, Johan Dahlén, Craig Mckenzie, Henrik Green (2023) The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards Journal of Analytical Toxicology, Vol. 47, p. 826-834 (Article in journal) Continue to DOI

Tobias Rautio, Daan Vangerven, Johan Dahlén, Shimpei Watanabe, Robert Kronstrand, Svante Vikingsson, Peter Konradsson, Xiongyu Wu, Henrik Gréen (2023) In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3-fluoro-methoxyacetylfentanyl, and 3-phenylpropanoylfentanyl using LC-QTOF-HRMS together with synthesized references Drug Testing and Analysis, Vol. 15, p. 711-729 (Article in journal) Continue to DOI

2022

Tobias Rautio, Jonathan Thornell, Henrik Gréen, Peter Konradsson, Johan Dahlén, Xiongyu Wu (2022) An improved procedure for the synthesis of fourteen 4-OH and 3-MeO-4OH metabolites of fentanyl analogues from two intermediates on multi-gram scale Synthetic Communications, Vol. 52, p. 392-401 (Article in journal) Continue to DOI